Lava Therapeutics
LVTX
$2.26
Share price
-5.83%
Change (1 day)
18.95%
Change (1 year)
Categories
Lava Therapeutics (LVTX) - P/B ratio
P/B ratio as of June 2024 : 1.26
According to Lava Therapeutics's latest financial reports the company has a price-to-book ratio of 1.26.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Lava Therapeutics - P/B ratio (from 2022 to 2021)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | 0.8116 | -24.11% |
| 2022-12-31 | 1.07 | 1.12% |
| 2021-12-31 | 1.06 | |
| 2020-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 1.83 | 45.28% | 🇺🇸 USA |